<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN">
<html>
<head>
<title>DCCPS: Health Behavior Constructs: Theory, Measurement, &#38; Research</title>
<link href="../../../styles.css" rel="stylesheet" type="text/css">
<script type="text/javascript">
function turnoff(obj) {
	var el = document.getElementById(obj);
	el.style.display = 'none';
}
/*  TOGGLE function, switches the span named in parentheses depending on its current status */
function toggle(obj) {
	var el = document.getElementById(obj);
	if ( el.style.display != 'none' ) {
		el.style.display = 'none';
	}
	else {
		el.style.display = '';
	}
}
</script>
<link href="../styles.css" rel="stylesheet" type="text/css">
</head>

<body bgcolor="#FFFFFF" leftmargin="0" topmargin="0" marginwidth="0" marginheight="0">
<!--- Cancer.gov banner --->
<table width="100%" border="0" cellspacing="0" cellpadding="0" bgcolor="#A90101">
  <tr bgcolor="#A90101">
    <td width="283" height="37" align="left"><a href="http://www.cancer.gov"><img src="../../../images/logotype.gif" alt="National Cancer Institute" width="283" height="37" border="0"></a></td>
	<td>&nbsp;</td>
	<td width="295" height="37" align="right"><a href="http://www.cancer.gov"><img src="../../../images/tagline.gif" alt="National Cancer Institute" width="295" height="37" border="0"></a></td>
  </tr>
</table><br />
<!--- End Cancer.gov banner --->

<table width="752" border="0" align="center" cellpadding="0" cellspacing="0">
  <tr>
    <td valign="top"><img src="../../../images/banner_constructs.jpg" alt="Behavioral Research" width="752" height="60" border="0" usemap="#Map"></td>
  </tr>
  <tr>
    <td width="782" valign="top">
	<table width="100%" border="0" cellspacing="0" cellpadding="0">
	  <tr valign="top">
	    <td width="162" rowspan="2"><br>
		<table width="100%" cellpadding="4" cellspacing="0" class="left-nav">
		  <tr>
            <td colspan="2"><strong>Table of Contents</strong></td>
          </tr>
          <tr valign="top">
            <td>1</td>
            <td width="100%"><a href="index.html">Introduction</a></td>
          </tr>
          <tr valign="top">
            <td>2</td>
            <td width="100%"><a href="sr2.html">Self-Report of Cancer Behaviors</a></td>
          </tr>
          <tr valign="top">
            <td>3</td>
            <td width="100%"><a href="sr3.html">Self-Reports of Family History</a></td>
          </tr>
        </table>

        <table width="100%"  border="0" cellpadding="4" cellspacing="0" bgcolor="#ffffff" class="left-nav-selected">
          <tr valign="top">
            <td><strong>4</strong></td>
            <td width="100%" bgcolor="#FFFFFF"><p><strong>Self-Reported Psychosocial Risk Factors among Cancer Patients</strong></p></td>
          </tr>
        </table>
		 
        <table width="100%"  border="0" cellpadding="4" cellspacing="0" class="left-nav">
          <tr valign="top">
            <td>5</td>
            <td><p><a href="sr5.html">Application of Self-Report Measures in Cancer</a></p></td>
          </tr>
          <tr valign="top">
            <td>6</td>
            <td><p><a href="sr6.html">Suggestions for Use of Self-Report for Cancer-Related Variables</a></p></td>
          </tr>
		  <tr valign="top">
		    <td>7</td>
			<td><a href="sr7.html">Overall Conclusions </a></td>
		  </tr>
		  <tr valign="top">
		    <td>8</td>
			<td><a href="sr8.html">References</a></td>
		  </tr>
          <tr valign="top">
		    <td>9</td>
			<td><a href="../references.html#srb">Published Examples</a></td>
		  </tr>
        </table><br>
		
		<table width="100%"  border="0" cellpadding="4" cellspacing="0" class="left-nav">
		  <tr>
		    <td><strong><a href="self-report.pdf">Download Full Text</a> (PDF)</strong></td>
		  </tr>
		</table><br>
		
		<table width="100%"  border="0" cellpadding="4" cellspacing="0" class="left-nav-other">
		  <tr valign="top">
		    <td colspan="2"><strong>Other Constructs </strong></td>
		  </tr>	  
		  <tr valign="top">
		    <td>&nbsp;</td>
			<td width="100%"><p><a href="../barriers/index.html">Barriers</a> </p></td>
		  </tr>
		  <tr valign="top">
		    <td>&nbsp;</td>
			<td width="100%"><p><a href="../dispositional_optimism/index.html">Dispositional Optimism</a> </p></td>
		  </tr>
		  <tr valign="top">
		    <td>&nbsp;</td>
			<td width="100%"><p><a href="../environment/index.html">Environments</a> </p></td>
		  </tr>
          <tr valign="top">
            <td>&nbsp;</td>
            <td><p><a href="../illness_representations/index.html">Illness Representations</a> </p></td>
          </tr>
          <tr valign="top">
            <td>&nbsp;</td>
            <td><a href="../implementation_intentions/index.html">Implementation Intentions</a></td>
          </tr>
          <tr valign="top">
            <td>&nbsp;</td>
            <td><a href="../intent-expect-willingness/index.html">Intention, Expectation, and Willingness</a> </td>
          </tr>
          <tr>
            <td>&nbsp;</td>
            <td><a href="../normative_beliefs/index.html">Normative Beliefs</a> </td>
          </tr>
          <tr>
            <td>&nbsp;</td>
            <td><a href="../optimistic_bias/index.html">Optimistic Bias</a> </td>
          </tr>
          <tr>
            <td>&nbsp;</td>
            <td><a href="../perceived_benefits/index.html">Perceived Benefits</a> </td>
          </tr>
          <tr>
            <td>&nbsp;</td>
            <td><a href="../perceived_control/index.html">Perceived Control</a> </td>
          </tr>
          <tr>
            <td>&nbsp;</td>
            <td><a href="../perceived_severity/index.html">Perceived Severity</a> </td>
          </tr>
          <tr>
            <td>&nbsp;</td>
            <td><a href="../perceived_vulnerability/index.html">Perceived Vulnerability</a> </td>
          </tr>
          <tr>
            <td>&nbsp;</td>
            <td><a href="../self-efficacy/index.html">Self-Efficacy</a></td>
          </tr>
          <tr>
            <td>&nbsp;</td>
            <td><a href="index.html">Self-Reported Behavior</a></td>
          </tr>
          <tr>
            <td>&nbsp;</td>
            <td><a href="../social_influence/index.html">Social Influence</a> </td>
          </tr>
          <tr>
            <td>&nbsp;</td>
            <td><a href="../social_support/index.html">Social Support</a> </td>
          </tr>
          <tr>
            <td>&nbsp;</td>
            <td><a href="../stages/index.html">Stages</a> </td>
          </tr>
          <tr>
            <td>&nbsp;</td>
            <td><a href="../worry/index.html">Worry</a></td>
          </tr>
         </table>
		 </td>
		 
	    <td>
		<table width="100%"  border="0" cellspacing="0" cellpadding="10">
         <tr>
            <td colspan="2"><p align="center"><span class="document-title">Self-Report of Cancer-Related Behaviors</span><br>
            <strong>Joshua M. Smyth, Monica S. Webb, and Masanori Oikawa</strong></p></td>
          </tr>
          <tr>
            <td><a href="sr3.html">&lt;&lt; Previous</a> </td>
            <td><div align="right"><a href="sr5.html">Next &gt;&gt;</a> </div></td>
          </tr>
          <tr>
            <td colspan="2">
			<table width="100%" cellpadding="2" cellspacing="0" border="0">
			  <tr valign="top">
			    <td width="2%"><h3>4</h3></td>
				<td><h3>Self-Reported Psychosocial Risk Factors among Cancer Patients</h3></td>
			  </tr>
			</table>
			</td>
          </tr>
          <tr>
            <td colspan="2">
            <p>Secondary and tertiary prevention research often assesses and intervenes on processes that affect the cancer experience. These include health-related quality of life and medical adherence and, <strong>because there are often no reliable biomedical markers for these factors, self-report is the primary assessment method</strong>. Although we describe both quality of life and medical adherence in more detail below, self-report can be more generally improved by including collateral reports from spouses or family members and/or utilizing structured clinical interviews (rather than &#34;paper and pencil&#34; self-report).</p>
            
            <p><strong>Quality of life</strong>. It is well established that many cancer patients experience reduced quality of life (QoL), and that QoL has become an important outcome measure in cancer research. Reduced QoL can be identified through specific limitations in physical, role, cognitive, emotional, and social functioning. QoL decrements have been well documented among multiple populations, such as in breast (<a href="javascript:toggle('ref1');" class="ref_link">Roth, Lowery, Davis, &#38; Wilkins, 2005</a><span id="ref1" style="display:none;" class="biblio_pop"> <a href="javascript:toggle('ref1');" class="close_butt"><span style="color: red;">x</span>Close</a><br>
            Roth, R.S., Lowery, J.C., Davis, J., &#38; Wilkins, E.G. (2005). Quality of life and affective distress in women seeking immediate versus delayed breast reconstruction after mastectomy for breast cancer. <em>Plastic and Reconstructive Surgery, 116(4)</em>, 993-1002.</span>) and colorectal cancer patients (<a href="javascript:toggle('ref2');" class="ref_link">Arndt, Merx, Stegmaier, Ziegler, &#38; Brenner, 2004</a><span id="ref2" style="display:none;" class="biblio_pop"> <a href="javascript:toggle('ref2');" class="close_butt"><span style="color: red;">x</span>Close</a><br>
            Arndt, V., Merx, H., Stegmaier, C., Ziegler, H., &#38; Brenner, H. (2004). Quality of life in patients with colorectal cancer 1 year after diagnosis compared with the general population: A population-based study. <em>Journal of Clinical Oncology, 22(23)</em>, 4829-4836.</span>), among many others. Researchers often create their own QoL self-report instruments, although several published measures are available (e.g., the SF-36; <a href="javascript:toggle('ref3');" class="ref_link">McHorney, Ware, Lu, &#38; Sherbourne, 1994</a><span id="ref3" style="display:none;" class="biblio_pop"> <a href="javascript:toggle('ref3');" class="close_butt"><span style="color: red;">x</span>Close</a><br>
            McHorney, C.A., Ware, Jr., J.E., Lu, J.F., &#38; Sherbourne, C.D. (1994). The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. <em>Medical Care, 32(1)</em>, 40-66.</span>).</p>
            
            <p>The <strong>Functional Assessment of Cancer Therapy</strong> (FACT-G; <a href="javascript:toggle('ref4');" class="ref_link">Cella et al., 1993</a><span id="ref4" style="display:none;" class="biblio_pop"> <a href="javascript:toggle('ref4');" class="close_butt"><span style="color: red;">x</span>Close</a><br>
            Cella, D.F., Tulsky, D.S., Gray, G., Sarafian, B., Lloyd, S., Linn, E., et al. (1993). The Functional Assessment of Cancer Therapy (FACT) scale: Development and validation of the general measure. <em>Journal of Clinical Oncology, 11(3)</em>, 570-579.</span>; <a href="javascript:toggle('ref5');" class="ref_link">Fairclough &#38; Cella, 1996</a><span id="ref5" style="display:none;" class="biblio_pop"> <a href="javascript:toggle('ref5');" class="close_butt"><span style="color: red;">x</span>Close</a><br>
            Fairclough, D.L., &#38; Cella, D.F. (1996). Functional Assessment of Cancer Therapy (FACT-G): Non-response to individual questions. <em>Quality of Life Research, 5</em>, 321-329.</span>) questionnaires are a validated set of general measures (n = 3), cancer specific measures (n = 18), cancer specific-symptom measures (n = 11), treatment specific measures (n = 4), and symptom specific measures (n = 12). Evidence suggests that the FACT-G has smaller coefficients of variations and larger effect sizes compared to other commonly used tools (<a href="javascript:toggle('ref6');" class="ref_link">Cheung, Goh, Thumboo, Khoo, &#38; Wee, 2005</a><span id="ref6" style="display:none;" class="biblio_pop"> <a href="javascript:toggle('ref6');" class="close_butt"><span style="color: red;">x</span>Close</a><br>
            Cheung, Y.B., Goh, C., Thumboo, J., Khoo, K.S., &#38; Wee, J. (2005). Variability and sample size requirements of quality-of-life measures: A randomized study of three major questionnaires. <em>Journal of Clinical Oncology, 23(22)</em>, 4936-4944.</span>). In addition to patient self-reports of QoL, physician evaluations may be valuable. In particular, some evidence suggests that <strong>physician reports are more sensitive in recognizing changes in patient physical or general health than are patient reports</strong> (<a href="javascript:toggle('ref7');" class="ref_link">Sneeuw et al., 1997</a><span id="ref7" style="display:none;" class="biblio_pop"> <a href="javascript:toggle('ref7');" class="close_butt"><span style="color: red;">x</span>Close</a><br>
            Sneeuw, K.C., Aaronson, N.K., Sprangers, M.A., Detmar, S.B., Wever, L.D., &#38; Schornagel, J.H. (1997). Value of caregiver ratings in evaluating the quality of life of patients with cancer. <em>Journal of Clinical Oncology, 15(3)</em>, 1206-1217.</span>). Caregiver reports may also be a complementary source of information, particularly when a patient report is judged to be less reliable (e.g., for social desirability reasons; <a href="javascript:toggle('ref8');" class="ref_link">Sneeuw et al., 1997</a><span id="ref8" style="display:none;" class="biblio_pop"> <a href="javascript:toggle('ref8');" class="close_butt"><span style="color: red;">x</span>Close</a><br>
            Sneeuw, K.C., Aaronson, N.K., Sprangers, M.A., Detmar, S.B., Wever, L.D., &#38; Schornagel, J.H. (1997). Value of caregiver ratings in evaluating the quality of life of patients with cancer. <em>Journal of Clinical Oncology, 15(3)</em>, 1206-1217.</span>).</p>
            
            <p><strong>Medical adherence</strong>. Most patients with cancer receive some form of treatment (oral, chemotherapy, or radiation) as part of their regimen. In these cases, medical adherence is essential to reduce morbidity and increase longevity. Multiple approaches are used to determine whether patients are taking their prescribed medication at the correct dosage and frequency (<a href="javascript:toggle('ref9');" class="ref_link">Atkins &#38; Fallowfield, 2006</a><span id="ref9" style="display:none;" class="biblio_pop"> <a href="javascript:toggle('ref9');" class="close_butt"><span style="color: red;">x</span>Close</a><br>
            Atkins, L., &#38; Fallowfield, L. (2006). Intentional and non-intentional non-adherence to medication amongst breast cancer patients. <em>European Journal of Cancer, 42</em>, 2271-2276.</span>), adhering to inpatient and outpatient treatments, and attending appointments. Treatment adherence can be assessed using both objective (e.g., drug levels in blood or urine) and subjective (e.g., diary, interview, or clinical interview self-report) methods.</p>
            
            <p>Although evidence suggests that poor adherence is a barrier to effective treatment (<a href="javascript:toggle('ref10');" class="ref_link">Atkins &#38; Fallowfield, 2006</a><span id="ref10" style="display:none;" class="biblio_pop"> <a href="javascript:toggle('ref10');" class="close_butt"><span style="color: red;">x</span>Close</a><br>
            Atkins, L., &#38; Fallowfield, L. (2006). Intentional and non-intentional non-adherence to medication amongst breast cancer patients. <em>European Journal of Cancer, 42</em>, 2271-2276.</span>; <a href="javascript:toggle('ref11');" class="ref_link">Hoagland, Morrow, Bennett, &#38; Carnrike, 1983</a><span id="ref11" style="display:none;" class="biblio_pop"> <a href="javascript:toggle('ref11');" class="close_butt"><span style="color: red;">x</span>Close</a><br>
            Hoagland, A.C., Morrow, G.R., Bennett, J.M., Carnrike, Jr., C.L. (1983). Oncologists’ views of cancer patient noncompliance. <em>American Journal of Clinical Oncology, 6(2)</em>, 239-244.</span>; <a href="javascript:toggle('ref12');" class="ref_link">Miaskowski et al., 2001</a><span id="ref12" style="display:none;" class="biblio_pop"> <a href="javascript:toggle('ref12');" class="close_butt"><span style="color: red;">x</span>Close</a><br>
            Miaskowski, C., Dodd, M.J., West, C., Paul, S.M., Tripathy, D., Koo, P., et al. (2001). Lack of adherence with the analgesic regimen: A significant barrier to effective cancer pain management. <em>Journal of Clinical Oncology, 19(23)</em>, 4275-4279.</span>), <strong>treatment adherence for cancers is generally higher than for other medical conditions</strong> (e.g., diabetes, sleep disorders, pulmonary diseases; see <a href="javascript:toggle('ref13');" class="ref_link">DiMatteo, 2004</a><span id="ref13" style="display:none;" class="biblio_pop"> <a href="javascript:toggle('ref13');" class="close_butt"><span style="color: red;">x</span>Close</a><br>
            DiMatteo, M.R. (2004). Variations in patients’ adherence to medical recommendations: A quantitative review of 50 years of research. <em>Medical Care, 42(3)</em>, 200-209.</span>; cf. <a href="javascript:toggle('ref14');" class="ref_link">Escalada &#38; Griffiths, 2006</a><span id="ref14" style="display:none;" class="biblio_pop"> <a href="javascript:toggle('ref14');" class="close_butt"><span style="color: red;">x</span>Close</a><br>
            Escalada, P. &#38; Griffiths, P. (2006). Do people with cancer comply with oral chemotherapy treatments? <em>British Journal of Community Nursing, 11(12)</em>, 532-536.</span>). Factors related to non-adherence have also been studied. For example, among breast cancer patients, poorer adherence is related to more prescriptions at baseline (<a href="javascript:toggle('ref15');" class="ref_link">Lash, Fox, Westrup, Fink, &#38; Silliman, 2006</a><span id="ref15" style="display:none;" class="biblio_pop"> <a href="javascript:toggle('ref15');" class="close_butt"><span style="color: red;">x</span>Close</a><br>
            Lash, T.L., Matthew, P.F., Westrup, J.L., Fink, A.K., &#38; Silliman, R.A. (2006). Adherence to tamoxifen over the five-year course. <em>Breast Cancer Research and Treatment, 99</em>, 215-220.</span>), treatment side effects or psychological distress (<a href="javascript:toggle('ref16');" class="ref_link">Demissie, Silliman, &#38; Lash, 2001</a><span id="ref16" style="display:none;" class="biblio_pop"> <a href="javascript:toggle('ref16');" class="close_butt"><span style="color: red;">x</span>Close</a><br>
            Demissie, S., Silliman, R.A., &#38; Lash, T.L. (2001). Adjuvant tamoxifen: Predictors of use, side effects, and discontinuation in older women. <em>Journal of Clinical Oncology, 19</em>, 322-328.</span>; <a href="javascript:toggle('ref17');" class="ref_link">Hoagland et al., 1983</a><span id="ref17" style="display:none;" class="biblio_pop"> <a href="javascript:toggle('ref17');" class="close_butt"><span style="color: red;">x</span>Close</a><br>
            Hoagland, A.C., Morrow, G.R., Bennett, J.M., Carnrike, Jr., C.L. (1983). Oncologists’ views of cancer patient noncompliance. <em>American Journal of Clinical Oncology, 6(2)</em>, 239-244.</span>), low medication efficacy expectations (<a href="javascript:toggle('ref18');" class="ref_link">Fink, Gurwitz, Radowski, &#38; Guadagnoli, &#38; Silliman, 2004</a><span id="ref18" style="display:none;" class="biblio_pop"> <a href="javascript:toggle('ref18');" class="close_butt"><span style="color: red;">x</span>Close</a><br>
            Fink, A., Gurwitz, J., Radowski, W., Guadagnoli, E., &#38; Silliman, R. (2004). Patient beliefs and tamoxifen discontinuation in older women with estrogen receptor-positive breast cancer. <em>Journal of Clinical Oncology, 22</em>, 3309-3315.</span>), positive node status (<a href="javascript:toggle('ref19');" class="ref_link">Demissie et al., 2001</a><span id="ref19" style="display:none;" class="biblio_pop"> <a href="javascript:toggle('ref19');" class="close_butt"><span style="color: red;">x</span>Close</a><br>
            Demissie, S., Silliman, R.A., &#38; Lash, T.L. (2001). Adjuvant tamoxifen: Predictors of use, side effects, and discontinuation in older women. <em>Journal of Clinical Oncology, 19</em>, 322-328.</span>; <a href="javascript:toggle('ref20');" class="ref_link">Fink et al., 2004</a><span id="ref20" style="display:none;" class="biblio_pop"> <a href="javascript:toggle('ref20');" class="close_butt"><span style="color: red;">x</span>Close</a><br>
            Fink, A., Gurwitz, J., Radowski, W., Guadagnoli, E., &#38; Silliman, R. (2004). Patient beliefs and tamoxifen discontinuation in older women with estrogen receptor-positive breast cancer. <em>Journal of Clinical Oncology, 22</em>, 3309-3315.</span>), better physical functioning (<a href="javascript:toggle('ref21');" class="ref_link">Demissie et al., 2001</a><span id="ref21" style="display:none;" class="biblio_pop"> <a href="javascript:toggle('ref21');" class="close_butt"><span style="color: red;">x</span>Close</a><br>
            Demissie, S., Silliman, R.A., &#38; Lash, T.L. (2001). Adjuvant tamoxifen: Predictors of use, side effects, and discontinuation in older women. <em>Journal of Clinical Oncology, 19</em>, 322-328.</span>), and younger age (<a href="javascript:toggle('ref22');" class="ref_link">Partridge, Wang, Winer, &#38; Avorn, 2003</a><span id="ref22" style="display:none;" class="biblio_pop"> <a href="javascript:toggle('ref22');" class="close_butt"><span style="color: red;">x</span>Close</a><br>
            Partridge, A., Wang, P., Winer, E., Avorn, J. (2003). Nonadherrence to adjuvant tamoxifen therapy in women with primary breast cancer. <em>Journal of Clinical Oncology, 21</em>, 602-606.</span>). <strong>However, the extant studies of treatment adherence (particularly outside of medication regimens) have generally relied on self-reports, with little research examining the validity of patients&#8217; self-reported adherence to cancer treatment</strong>. A necessary first step appears to be the generation of standardized definitions and instruments for treatment adherence assessments in cancer patients (<a href="javascript:toggle('ref23');" class="ref_link">Escalada &#38; Griffiths, 2006</a><span id="ref23" style="display:none;" class="biblio_pop"> <a href="javascript:toggle('ref23');" class="close_butt"><span style="color: red;">x</span>Close</a><br>
            Escalada, P. &#38; Griffiths, P. (2006). Do people with cancer comply with oral chemotherapy treatments? <em>British Journal of Community Nursing, 11(12)</em>, 532-536.</span>). In addition, researchers assessing medical compliance should include items that differentiate intentional (willful) versus non-intentional noncompliance (<a href="javascript:toggle('ref24');" class="ref_link">Atkins &#38; Fallowfield, 2006</a><span id="ref24" style="display:none;" class="biblio_pop"> <a href="javascript:toggle('ref24');" class="close_butt"><span style="color: red;">x</span>Close</a><br>
            Atkins, L., &#38; Fallowfield, L. (2006). Intentional and non-intentional non-adherence to medication amongst breast cancer patients. <em>European Journal of Cancer, 42</em>, 2271-2276.</span>).</p>
            
            <p>In short, research among cancer populations includes multiple psychosocial factors that are measured using self-report. Evidence exists for the validity of existing tools to measure quality of life. Additional methods of assessing medical adherence are needed. We will see tremendous advancements as innovative methods are developed to measure these constructs.</p>
            </td>
          </tr>
          <tr>
            <td><a href="sr3.html">&lt;&lt; Previous</a> </td>
            <td><div align="right"><a href="sr5.html">Next &gt;&gt;</a> </div></td>
          </tr>
        </table>	      
	      <p align="right"></p></td>
        </tr>
	  </table></td>
  </tr>
</table>
</div>
	  
<table width="100%" border="0" cellspacing="0" cellpadding="0">
  <tr>
    <td valign="top"><div align="center">
	<p><img src="../../../images/footer_stripe.jpg" alt=" " width="755" height="7"></p>
	
	<p><a href="../../../search.html" class="gray-link">Search</a> | <a href="../../../help.html" class="gray-link">Help</a> | <a href="../../../contact.html" class="gray-link">Contact Us</a> | <a href="http://www.cancer.gov/global/web/policies/accessibility" class="gray-link">Accessibility</a>  | <a href="../../../privacy-policy.html" class="gray-link">Privacy Policy</a></p>
	
	<p><a href="http://cancercontrol.cancer.gov"><img src="../../../images/footer_dccps.gif" alt="DCCPS" width="58" height="31" border="0"></a><a href="http://www.cancer.gov/"><img src="../../../images/footer_nci.gif" width="63" height="31" alt="National Cancer Institute" border="0"></a>
	<a href="http://www.dhhs.gov/"><img src="../../../images/footer_hhs.gif" width="39" height="31" alt="Department of Health and Human Services" border="0"></a>
	<a href="http://www.nih.gov/"><img src="../../../images/footer_nih.gif" width="46" height="31" alt="National Institutes of Health" border="0"></a>
	<a href="http://www.USA.gov/"><img src="../../../images/footer_firstgov.gif" width="91" height="31" alt="USA.gov" border="0"></a></p>
	</div>
	</td>
  </tr>
</table>

<map name="Map">
  <area shape="rect" coords="1,2,751,59" href="../index.html" alt="Health Behavior Constructs: Theory, Measurement, &#38; Research">
</map>


</body>
</html>
